Castle Biosciences's market cap is currently $732.39M. The company's EPS TTM is $0.199; its P/E ratio is 130.82; Castle Biosciences is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 219.79M	$ 137.04M	$ 94.08M	$ 62.65M	$ 51.87M
Gross Profit	$ 174.81M	$ 105.03M	$ 78.26M	$ 52.96M	$ 44.55M
Operating Income	$ -67.98M	$ -91.14M	$ -40.08M	$ -6.54M	$ 4.71M
EBITDA	$ -45.02M	$ -58.34M	$ -36.60M	$ -7.09M	$ 7.69M
Net Income	$ -57.47M	$ -67.14M	$ -31.29M	$ -10.28M	$ 5.28M
Balance Sheet
Cash & Short-Term Investments	$ 243.10M	$ 258.63M	$ 329.63M	$ 409.85M	$ 98.84M
Total Assets	$ 453.34M	$ 447.33M	$ 462.57M	$ 439.33M	$ 119.75M
Total Debt	$ 15.34M	$ 13.31M	$ 8.08M	$ 0.00	$ 25.12M
Net Debt	$ -83.51M	$ -109.64M	$ -321.55M	$ -409.85M	$ -73.72M
Total Liabilities	$ 62.07M	$ 48.18M	$ 50.83M	$ 23.64M	$ 34.63M
Stockholders' Equity	$ 391.27M	$ 399.15M	$ 411.74M	$ 415.69M	$ 85.11M
Cash Flow
Free Cash Flow	$ -19.25M	$ -47.29M	$ -22.47M	$ 5.11M	$ 6.08M
Operating Cash Flow	$ -5.63M	$ -41.66M	$ -18.98M	$ 9.87M	$ 7.01M
Investing Cash Flow	$ -16.18M	$ -166.54M	$ -66.66M	$ -4.75M	$ -937.00K
Financing Cash Flow	$ -2.30M	$ 1.51M	$ 5.42M	$ 305.89M	$ 88.29M

Currency in USD

Castle Biosciences Earnings and Revenue History

Income Statement >

Castle Biosciences Debt to Assets

Balance Sheet >

Castle Biosciences Cash Flow

Cash Flow >

Castle Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing